Benign thyroid diseases: a public health problem aggravated in times of COVID-19 pandemic

This article focuses solely on benign thyroid pathologies and the implications of their treatment in "Times of COVID-19 Pandemic", March 2021.The text aims to inform as well as raise questions, the basis of a healthy scientific evolution, with subsequent application in favor of patients. Benign thyroid diseasesOver 90% of the nodules detected in the thyroid are indolent benign lesions, and approximately 4-7% are carcinomas.The diagnosis of benign lesions is reached through clinical examination, and mostly by Ultrasound 1,2 .Nodules are highly prevalent, most of them are 1.0 cm in diameter at diagnosis, barely palpable, and with no glandular dysfunction.Recent studies have shown that these nodules present slow, progressive growth -limited to ~5 mm over 5 years in the main nodule in cases of multinodular disease, are mostly asymptomatic, require no treatment, and can be monitored 1 .Signs indicative of compressive goiter in the air-digestive tract include the onset of symptoms of dysphagia, dyspnea on recumbency, sensation of a